Want to see AU:4DX full AI Analyst Report?
4DX Stock Chart & Stats
AU$3.88
AU$0.17(5.47%)
At close: 4:00 PM EDT
AU$3.88
AU$0.17(5.47%)
Day’s Range― - ―
52-Week RangeAU$1.40 - AU$7.55
Previous CloseN/A
Volume3.54M
Average Volume (3M)4.10M
Market Cap
AU$2.29B
Enterprise ValueAU$2.43K
Total Cash (Recent Filing)AU$277.95M
Total Debt (Recent Filing)AU$3.22M
Price to Earnings (P/E)―
Beta2.59
Next Earnings
Feb 26, 2027EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding601,571,600
10 Day Avg. Volume3,343,377
30 Day Avg. Volume4,102,241
Financial Highlights & Ratios
PEG Ratio1.92
Price to Book (P/B)181.41
Price to Sales (P/S)4371.54
P/FCF Ratio-957.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$5.05Price Target Upside30.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.05
Revenue Forecast (FY)AU$20.95M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe sharp 2026 revenue increase indicates that 4DMedical is scaling adoption of its respiratory imaging and analysis offering. Continued top-line expansion can broaden its customer base, increase platform utilization, and provide operating leverage if cost growth moderates.
Low Financial LeverageVery low leverage reduces financial risk and preserves flexibility while the company invests in commercial expansion. A sizable equity base also provides resilience against operating volatility, limits interest-related pressure, and leaves more strategic options than a highly indebted balance sheet.
Recurring Software MonetizationA software-led model with licensing, subscription, and usage-based revenue can support repeat customer relationships and rising revenue as clinical utilization grows. Implementation and support services may also help embed the platform in workflows and support longer-term account retention.
Bears Say
Persistent Operating LossesOngoing operating losses show that revenue growth has not yet translated into a sustainable profit model. Without improving cost absorption and margins, additional sales may require continued funding and may not create durable shareholder value over the next several quarters.
Continued Cash BurnPersistent negative operating and free cash flow means the business continues to consume cash while funding operations and expansion. Even though 2026 burn moderated, the ongoing financing requirement can constrain investment choices and increase exposure to future capital needs.
2026 Gross Profit DeteriorationThe negative gross profit outcome in 2026 signals severe cost pressure or unusual impacts at the gross-profit level, beyond ordinary operating expenses. If not reversed, this deterioration could undermine the economics of each customer engagement and delay the path to break-even.
4DMedical Ltd News
4DX FAQ
What was 4DMedical Ltd’s price range in the past 12 months?
4DMedical Ltd lowest share price was AU$1.40 and its highest was AU$7.55 in the past 12 months.
What is 4DMedical Ltd’s market cap?
4DMedical Ltd’s market cap is AU$2.29B.
When is 4DMedical Ltd’s upcoming earnings report date?
4DMedical Ltd’s upcoming earnings report date is Feb 26, 2027 which is in 160 days.
How were 4DMedical Ltd’s earnings last quarter?
4DMedical Ltd released its earnings results on Aug 28, 2026. The company reported AU$0.229 earnings per share for the quarter, beating the consensus estimate of -AU$0.04 by AU$0.269.
Is 4DMedical Ltd overvalued?
According to Wall Street analysts 4DMedical Ltd’s price is currently Undervalued.
Does 4DMedical Ltd pay dividends?
4DMedical Ltd does not currently pay dividends.
What is 4DMedical Ltd’s EPS estimate?
4DMedical Ltd’s EPS estimate is -0.03.
How many shares outstanding does 4DMedical Ltd have?
4DMedical Ltd has 601,571,600 shares outstanding.
What happened to 4DMedical Ltd’s price movement after its last earnings report?
4DMedical Ltd reported an EPS of AU$0.229 in its last earnings report, beating expectations of -AU$0.04. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of 4DMedical Ltd?
Currently, no hedge funds are holding shares in AU:4DX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
4DMedical Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$5.05 (30.15% Upside)
AU$5.05 (30.15% Upside)
Blogger Sentiment
Bullish
AU:4DX Sentiment 95%
Sector Average 62%
Sector Average 62%
Insider Transactions
Bought Shares
Worth AU$100.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
102.12%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
285.33%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
4DMedical Ltd
Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical Limited operates as a medical technology enterprise across Australia and the United States. The company primarily focuses on bringing to market its innovative XV Technology, an advanced system for four-dimensional lung imaging. Beyond this core offering, its suite of products includes a software-as-a-service (SaaS) delivery model, specialized XV lung ventilation analysis software, and Permetium—a preclinical imaging system designed to quantify regional changes in pulmonary function. Additionally, the firm provides the AccuVent 200, a ventilator tailored for small animals.
4DX Stock 12 Month Forecast
Average Price Target
AU$5.05
▲(30.15% Upside)
Technical Analysis
Compumedics Limited
―
Somnomed Limited
―
Cyclopharm Limited
―
EMvision Medical Devices Ltd.
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―









